These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SLE syndrome with keratoconjunctivitis sicca, a side-effect of practolol [proceedings]. Poelhuis JW; Donders PC; Schweitzer NM Ophthalmologica; 1977; 175(1):40. PubMed ID: 904901 [No Abstract] [Full Text] [Related]
5. Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin). Sondergaard J; Wadskov S; Jensen HA; Mikkelsen HI Acta Derm Venereol; 1976; 56(3):239-43. PubMed ID: 59510 [TBL] [Abstract][Full Text] [Related]
6. [Bilateral pleural effusion after practolol (author's transl)]. Lemola M; Ahonen A Schweiz Rundsch Med Prax; 1977 May; 66(22):676-8. PubMed ID: 141663 [No Abstract] [Full Text] [Related]
7. [Complications in treatment with beta blockader Practolol (Eraldin)]. Brinck HP; Aasved H; Jacobsen KB Tidsskr Nor Laegeforen; 1975 Aug; 95(24):1357-9, 1352. PubMed ID: 126503 [No Abstract] [Full Text] [Related]
8. Letter: Practolol and the eye. Ismail SA Br Med J; 1974 Oct; 4(5936):104. PubMed ID: 4414348 [No Abstract] [Full Text] [Related]
9. Beta-blockers, eye complaints, and tear secretion. Mackie IA; Seal DV Lancet; 1977 Nov; 2(8046):1027. PubMed ID: 72919 [No Abstract] [Full Text] [Related]
10. Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. Amos HE; Lake BG; Artis J Br Med J; 1978 Feb; 1(6110):402-4. PubMed ID: 146533 [TBL] [Abstract][Full Text] [Related]
11. [Practolol (Eraldin)]. van der Meer J Ned Tijdschr Geneeskd; 1975 Jun; 119(25):999-1000. PubMed ID: 49864 [No Abstract] [Full Text] [Related]
12. [Keratonconjuctivitis sicca with conjunctival shrinkage in the course of Dalzic treatment]. Severin M Klin Monbl Augenheilkd; 1974 Dec; 165(6):941-5. PubMed ID: 4465534 [No Abstract] [Full Text] [Related]
13. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Behan PO; Behan WM; Zacharias FJ; Nicholls JT Lancet; 1976 Nov; 2(7993):984-7. PubMed ID: 62263 [TBL] [Abstract][Full Text] [Related]
14. [Dry eye syndrome induced by carbamazepine]. García Martín M; Carreras Soler MJ; Jódar Masanés R; Linares Uribe F Rev Clin Esp; 1987 Dec; 181(9):544. PubMed ID: 3448670 [No Abstract] [Full Text] [Related]
15. Drugs causing intestinal obstruction: a review. George CF J R Soc Med; 1980 Mar; 73(3):200-4. PubMed ID: 7230203 [No Abstract] [Full Text] [Related]
16. An instructive example of a long-latency adverse drug reaction--sclerosing peritonitis due to practolol. Mann RD Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1211-6. PubMed ID: 17853493 [TBL] [Abstract][Full Text] [Related]
17. Slow-release artificial tear inserts in the treatment of dry eyes resulting from the oculomucocutaneous syndrome. Wright P; Vogel R Br J Ophthalmol; 1983 Jun; 67(6):393-7. PubMed ID: 6849861 [TBL] [Abstract][Full Text] [Related]
19. [Drug allergy induced salivary and lacrimal diseases: clinical analysis of 25 cases ]. Zhu ZH; Yu GY; Zhou LH; Xu L; Zhang SY Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):422-3. PubMed ID: 15854538 [No Abstract] [Full Text] [Related]
20. A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol. Mann RD Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):705-10. PubMed ID: 16088980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]